Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
11.11
-0.39 (-3.39%)
Sep 23, 2026, 10:54 AM EDT - Market open
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.88 billion as of September 23, 2026. Its market cap has increased by 156.80% in one year.
Market Cap
1.88B
Enterprise Value
1.44B
1-Year Change
156.80%
Ranking
Category
Stock Price
$11.11
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.88B, an increase of 22.57%. That is a compound annual growth rate of 2.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.88B | 124.10% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.06B |
| Mesoblast | 2.01B |
| Rapport Therapeutics | 1.99B |
| Lakefront Biotherapeutics NV | 1.96B |
| Zymeworks | 1.96B |
| Fortrea Holdings | 1.94B |
| Maravai LifeSciences Holdings | 1.94B |
| GH Research | 1.91B |